<p class="title">Majority of Fortis Healthcare's board opted for the Munjals-Burmans offer keeping in mind the certainty and liquidity issues, the company's director Brian W Tempest said on Friday.</p>.<p class="title">While five board members had voted in favour of the Rs 1,800-crore offer, three members had opted for other offers out of the four binding bids that Fortis Healthcare had received.</p>.<p class="bodytext">"We looked at all the binding bids from the point of view of certainty and liquidity for the company...We took advice from the expert committee, from two financial organisations and from a legal organisation," Tempest told reporters here.</p>.<p class="bodytext">When asked if the decision was unanimous, he said three members of the board, who have been with Fortis, voted for the Munjals-Burmans bid and out of five new members two voted for the bid and three voted for other options.</p>.<p class="bodytext">Another major reason for accepting the bid was that "they have several investments in the healtcare sector".</p>.<p class="bodytext">Accepting the offer was a culmination of a process which started two years ago, Tempest said, adding that it would now be presented to shareholders for approval.</p>.<p class="bodytext">"There will be a shareholders' meeting on this within 30 days and I am positive that there will be a support from the shareholders for the decision," he said.</p>.<p class="bodytext">On the issue of erstwhile promoters Malvinder Singh and Shivinder Singh continuing on the board of diagnostics chain SRL, Tempest said they should step down.</p>.<p class="bodytext">On the immediate task of the management of the cash-strapped healthcare chain, he said, "I would want them to focus on the performance and results of the of hospital business."</p>.<p class="bodytext">Fortis announced last night that its board has picked the offer from Munjals-Burmans combine over four other suitors who made binding offers.</p>.<p class="bodytext">The board decided by majority to recommend to shareholders to approve the revised offer of Hero Enterprise Investment Office and Burman Family Office (Dabur group) made on May 1 for an upfront equity infusion of Rs 800 crore at a price of Rs 167 per share through preferential allotment.</p>.<p class="bodytext">The Munjals-Burmans further agreed to invest another Rs 1,000 crore via preferential issue of warrants priced at Rs 176 per share.</p>.<p class="bodytext">Malaysia's IHH Healthcare, Manipal-TPG combine and KKR-backed Radiant Life Care had also put in binding bids for Fortis.</p>.<p class="bodytext">The fifth bidder, Fosun Health Holdings, an arm of Fosun International, which made a non-binding proposal to invest a total of $350 million (over Rs 2,295 crore) at a price up to Rs 156 per share, did not revise its offer.</p>.<p class="bodytext">"Disappointed" over losing the race to acquire Fortis Healthcare, Malaysia's IHH Healthcare said today that it is currently evaluating options while seeking support from shareholders of the Indian firm.</p>
<p class="title">Majority of Fortis Healthcare's board opted for the Munjals-Burmans offer keeping in mind the certainty and liquidity issues, the company's director Brian W Tempest said on Friday.</p>.<p class="title">While five board members had voted in favour of the Rs 1,800-crore offer, three members had opted for other offers out of the four binding bids that Fortis Healthcare had received.</p>.<p class="bodytext">"We looked at all the binding bids from the point of view of certainty and liquidity for the company...We took advice from the expert committee, from two financial organisations and from a legal organisation," Tempest told reporters here.</p>.<p class="bodytext">When asked if the decision was unanimous, he said three members of the board, who have been with Fortis, voted for the Munjals-Burmans bid and out of five new members two voted for the bid and three voted for other options.</p>.<p class="bodytext">Another major reason for accepting the bid was that "they have several investments in the healtcare sector".</p>.<p class="bodytext">Accepting the offer was a culmination of a process which started two years ago, Tempest said, adding that it would now be presented to shareholders for approval.</p>.<p class="bodytext">"There will be a shareholders' meeting on this within 30 days and I am positive that there will be a support from the shareholders for the decision," he said.</p>.<p class="bodytext">On the issue of erstwhile promoters Malvinder Singh and Shivinder Singh continuing on the board of diagnostics chain SRL, Tempest said they should step down.</p>.<p class="bodytext">On the immediate task of the management of the cash-strapped healthcare chain, he said, "I would want them to focus on the performance and results of the of hospital business."</p>.<p class="bodytext">Fortis announced last night that its board has picked the offer from Munjals-Burmans combine over four other suitors who made binding offers.</p>.<p class="bodytext">The board decided by majority to recommend to shareholders to approve the revised offer of Hero Enterprise Investment Office and Burman Family Office (Dabur group) made on May 1 for an upfront equity infusion of Rs 800 crore at a price of Rs 167 per share through preferential allotment.</p>.<p class="bodytext">The Munjals-Burmans further agreed to invest another Rs 1,000 crore via preferential issue of warrants priced at Rs 176 per share.</p>.<p class="bodytext">Malaysia's IHH Healthcare, Manipal-TPG combine and KKR-backed Radiant Life Care had also put in binding bids for Fortis.</p>.<p class="bodytext">The fifth bidder, Fosun Health Holdings, an arm of Fosun International, which made a non-binding proposal to invest a total of $350 million (over Rs 2,295 crore) at a price up to Rs 156 per share, did not revise its offer.</p>.<p class="bodytext">"Disappointed" over losing the race to acquire Fortis Healthcare, Malaysia's IHH Healthcare said today that it is currently evaluating options while seeking support from shareholders of the Indian firm.</p>